Skip to main content

Advertisement

Log in

The clinical significance of calcium/magnesium ratio in primary hyperparathyroidism: unveiling a clinical association

  • Original Article
  • Published:
Hormones Aims and scope Submit manuscript

Abstract

Purpose

In previous studies, magnesium (Mg) was found to be lower in cases with more severe primary hyperparathyroidism (PHPT) and higher calcium (Ca) levels. This study evaluated the relationship between serum Mg and serum Ca and phosphorus (P) levels in PHPT and their utility in determining the presence of osteoporosis and nephrolithiasis.

Methods

Patients who were followed up with PHPT between March 2019 and March 2023 were analyzed retrospectively. Biochemical data, renal ultrasonography results, dual-energy x-ray absorptiometry (DEXA) reports, and technetium 99 m sestamibi parathyroid scintigraphy reports were obtained. MgxP, Mg/P, Ca/P, and corrected Ca (cCa)/P values were calculated. The relationships between biochemical parameters and clinical outcomes were evaluated statistically.

Results

A total of 543 patients were included in the study. Patients with nephrolithiasis had higher cCa/Mg or Ca/Mg than those without nephrolithiasis. Additionally, ROC analysis revealed that cCa/Mg greater than 5.24 could identify the presence of nephrolithiasis with a sensitivity of 73.3% and a specificity of 73%. No statistically significant correlation existed between the results of the Mg/P, MgxP, cCa/Mg, Ca/Mg values, and DEXA-bone mineral densitometry(BMD).

Conclusion

Ca/Mg and cCa/Mg ratios in particular seem more valuable in determining the presence of nephrolithiasis than the currently used 24-h urine Ca measurement. Compared to urinary Ca measurements, they are cheaper, more practical, and more accessible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Amy Liu I-L, Harari A et al (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98(3):1122–1129. https://doi.org/10.1210/jc.2012-4022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14(2):115–125. https://doi.org/10.1038/nrendo.2017.104

    Article  CAS  PubMed  Google Scholar 

  3. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341(17):1249–1255. https://doi.org/10.1056/NEJM199910213411701

    Article  CAS  PubMed  Google Scholar 

  4. Rejnmark L, Vestergaard P, Mosekilde L (2011) Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 96(8):2377–2385. https://doi.org/10.1210/jc.2011-0569

    Article  CAS  PubMed  Google Scholar 

  5. Na D, Tao G, Shu-Ying L, Qin-Yi W, Xiao-Li Q, Yong-Fang L et al (2021) Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study. BMC Endocr Disord 21:1–8. https://doi.org/10.1186/s12902-021-00838-y

    Article  CAS  Google Scholar 

  6. Steen O, Khan A (2015) Role of magnesium in parathyroid physiology. Hypoparathyroidism 61–67. https://doi.org/10.1007/978-88-470-5376-2_7

  7. Crook M, Hally V, Panteli J (2001) The importance of the refeeding syndrome. Nutrition 17(7–8):632–637. https://doi.org/10.1016/s0899-9007(01)00542-1

    Article  CAS  PubMed  Google Scholar 

  8. King R, Stanbury S (1970) Magnesium metabolism in primary hyperparathyroidism. Clin Sci 39(2):281–303. https://doi.org/10.1042/cs0390281

    Article  CAS  PubMed  Google Scholar 

  9. Barnes BA, Krane SM, Cope O (1957) Magnesium studies in relation to hyperparathyroidism. J Clin Endocrinol Metab 17(12):1407–1421. https://doi.org/10.1210/jcem-17-12-1407

    Article  CAS  PubMed  Google Scholar 

  10. Hanna S, North K, MacIntyre I, Fraser R (1961) Magnesium metabolism in parathyoid disease. Br Med J 2(5262):1253. https://doi.org/10.1042/cs0390281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sutton R (1970) Plasma magnesium concentration in primary hyperparathyroidism. Br Med J 1(5695):529–533. https://doi.org/10.1136/bmj.1.5695.529

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Silverberg SJ, Bilezikian JP (1996) Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 81(6):2036–2040. https://doi.org/10.1210/jcem.81.6.8964825

    Article  CAS  PubMed  Google Scholar 

  13. Cosman F, de Beur SJ, LeBoff M, Lewiecki E, Tanner B, Randall S et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381. https://doi.org/10.1007/s00198-014-2794-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mollerup CL, Vestergaard P, Frøkjær VG, Mosekilde L, Christiansen P, Blichert-Toft M (2002) Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 325(7368):807. https://doi.org/10.1136/bmj.325.7368.807

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wu B, Haigh PI, Hwang R, Ituarte PH, Liu I-LA, Hahn TJ et al (2010) Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab 95(9):4324–4330. https://doi.org/10.1210/jc.2009-2819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gopal R, Acharya S, Bandgar T, Menon P, Dalvi A, Shah N (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56(2):79. https://doi.org/10.4103/0022-3859.65279

    Article  CAS  PubMed  Google Scholar 

  17. Bilezikian JP, Potts JT Jr, Fuleihan GE-H, Kleerekoper M, Neer R, Peacock M et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87(12):5353–5361. https://doi.org/10.1210/jc.2002-021370

    Article  CAS  PubMed  Google Scholar 

  18. Kukora JS, Zeiger MA, Clark OH, Grant CS, Hodgson SF, Irvin GL et al (2005) The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 11(1):49–54. https://doi.org/10.4158/EP.11.1.49

    Article  Google Scholar 

  19. Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh Q-Y, Stoller ML (2009) Patients with primary hyperparathyroidism—why do some form stones? J Urol 181(5):2141–2145. https://doi.org/10.1016/j.juro.2009.01.028

    Article  CAS  PubMed  Google Scholar 

  20. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569. https://doi.org/10.1210/jc.2014-1413

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GEH, Marcocci C, Minisola S et al (2022) Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 37(11):2293–2314. https://doi.org/10.1002/jbmr.4677

    Article  PubMed  Google Scholar 

  22. Song CH, Barrett-Connor E, Chung JH, Kim SH, Kim KS (2007) Associations of calcium and magnesium in serum and hair with bone mineral density in premenopausal women. Biol Trace Elem Res 118:1–9. https://doi.org/10.1007/s12011-007-0011-2

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Ekin Yiğit Köroğlu, Abbas Ali Tam, and Didem Özdemir; data curation: Ekin Yiğit Köroğlu and Sevgül Fakı; formal analysis: Ekin Yiğit Köroğlu and Belma Tural Balsak; funding acquisition: Ekin Yiğit Köroğlu; investigation: Ekin Yiğit Köroğlu and Abbas Ali Tam; methodology: Ekin Yiğit Köroğlu, Abbas Ali Tam, and Didem Özdemir; project administration: Ekin Yiğit Köroğlu, Fatma Ayça Edis Özdemir, and Sevgül Fakı; resources: Oya Topaloğlu, Reyhan Ersoy, and Bekir Çakır; software: Ekin Yiğit Köroğlu; supervision: Oya Topaloğlu, Reyhan Ersoy, and Bekir Çakır; validation: Didem Özdemir and Bekir Çakır; visualization: Ekin Yiğit Köroğlu; writing—original draft: Ekin Yiğit Köroğlu; writing—review and editing: Abbas Ali Tam and Didem Özdemir.

Corresponding author

Correspondence to Ekin Yiğit Köroğlu.

Ethics declarations

Ethical approval

Ankara City Hospital’s ethical committee approval was obtained on March 22nd, 2023 (E1-23-3406), in accordance with the ethical standards of the Declaration of Helsinki.

Informed consent

Informed consent was obtained from all participants included in the study.

Conflict of interest

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Köroğlu, E.Y., Tam, A.A., Fakı, S. et al. The clinical significance of calcium/magnesium ratio in primary hyperparathyroidism: unveiling a clinical association. Hormones (2024). https://doi.org/10.1007/s42000-024-00530-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s42000-024-00530-5

Keywords

Navigation